Symbicort SMART (Symbicort Maintenance And Reliever Therapy)
Completed
- Conditions
- Asthma
- Registration Number
- NCT00523679
- Lead Sponsor
- AstraZeneca
- Brief Summary
The purpose of this study is to investigate the extent of Symbicort use in patients prescribed Symbicort as maintenance and reliever therapy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 2000
Inclusion Criteria
- Asthma patients prescribed Symbicort as maintenance and reliever therapy, according to the label, before inclusion in this program.
Read More
Exclusion Criteria
- Since this programme intends to describe Symbicort use in routine clinical practice when prescribed as Symbicort maintenance and reliever therapy, there are no programme specific exclusion criteria, other than: involvement in the planning and conduct of the programme (applies to both AstraZeneca staff or staff at the investigational site)
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Research Site
🇰🇷Seoul, Songpa-gu, Korea, Republic of